Lipid-lowering therapies – strengths, weaknesses, opportunities, threats

shutterstock_299002157 - lipid lowering - Image for Home page

There's a strong evidence base for the safety and tolerability of many lipid-lowering drugs, including cholestyramine, statins, ezetimibe, PCSK9's and bempedoic acid

An understanding of:

  • The evidence demonstrating safety and efficacy of many lipid-lowering therapies
  • Factors that have an impact on trends in cardiovascular disease morbidity and mortality, and the roles of prevention and intervention strategies
  • New lipid-lowering therapies currently available and new therapeutic targets currently under investigation
  • Contemporary treatment of dyslipidaemia

To access this module, please register or login: